Product Code: 03-NGSS-SNV-26
From £1159.00
Deadline to order: 28/02/2026
EQA for quality of NGS for somatic SNVs and indels <50bp (FFPE). For NGS NOT requiring a matched normal control germline sample (single gene, panel testing, whole exome sequencing or whole genome sequencing). Pilot EQA.
Any somatic NGS strategy can be used (single gene, panel testing, exome or genome sequencing) that DOES NOT require a matched normal control sample. The scheme will assess all variants 50bp or less in size. Larger (>50bp in size) changes including copy number and structural variants (CNV’s, SV’s) are covered in a pilot EQA currently in development (please contact office@emqn.org for more information).
NGS, Panel testing, Whole exome sequencing, Whole genome sequencing
Not applicable
DNA (in TE Buffer)
No
September 2026
September - November 2026
You can complete purchase on our secure partner site.
The scheme is designed to assess the analytical process (genotyping) and quality of the raw data.
Please see our DNA SEQUENCING – NGS (Somatic SNVs and indels + matched germline sample) EQA scheme if you require a matched sample.
One mock clinical case and matching tumour DNA sample will be provided. Approximately 500ng DNA per sample is provided. Complete information will be available in the scheme instructions.
Participants will receive a comprehensive individual data quality report and a variant consensus analysis report for each submission. A comprehensive summary scheme report is provided including additional information from the cohort of participants including geographical spread, methodologies employed, common errors, learning points and scheme statistics allowing participants to benchmark their results.
Each laboratory will also receive a single certificate listing all EQAs participated in with performance result for each year.
Any somatic NGS strategy can be used (single gene, panel testing, exome or genome sequencing) that DOES NOT require a matched normal control sample.
Participants are expected to test samples according to their routine NGS strategy, to submit VCF, BED, FASTQ and BAM files for analysis.
Laboratories can submit up to three different SNV / indel data sets per participation, derived from different analyses of the EQA sample (e.g. different panels or methodologies).
No restrictions on number of participants. Open to laboratories from ALL countries (note: some restrictions may apply due to sanctions, delivery network exceptions, restrictions on importation etc). This EQA is provided in collaboration with GenQA.
added wishlist!
View Wishlist
View Wishlist
Express your interest in ''.
